G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Carcinoma, Ductal, Breast|Breast Cancer Female|Breast Neoplasm|Breast Cancer|Metastatic Breast Cancer|Advanced Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: G1T48|DRUG: Palbociclib
Sponsor: G1 Therapeutics, Inc.